ES2133633T3 - Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion. - Google Patents

Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion.

Info

Publication number
ES2133633T3
ES2133633T3 ES95113398T ES95113398T ES2133633T3 ES 2133633 T3 ES2133633 T3 ES 2133633T3 ES 95113398 T ES95113398 T ES 95113398T ES 95113398 T ES95113398 T ES 95113398T ES 2133633 T3 ES2133633 T3 ES 2133633T3
Authority
ES
Spain
Prior art keywords
pelets
granulates
powders
procedure
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95113398T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Jurgen Werry
Jurgen Freidenreich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2133633(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4201173A external-priority patent/DE4201173C2/de
Priority claimed from DE4201179A external-priority patent/DE4201179A1/de
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Application granted granted Critical
Publication of ES2133633T3 publication Critical patent/ES2133633T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

LA INVENCION SE REFIERE UN PROCEDIMIENTO PARA LA ELABORACION DE AL MENOS UN POLVO CONTENIENDO SUSTANCIA ACTIVA, GRANULADO O PELETS, CON MACROMOLECULAS HIDROFILAS, SUSTANCIA ACTIVA Y EVENTUALMENTE OTRAS SUSTANCIAS AUXILIARES Y DE ARMADURA ACEPTABLE FARMACEUTICAMENTE, DONDE LA SUSTANCIA ACTIVA SE ENCUENTRA ACTIVA EN UNA MATRIZ, SUSPENDIDA O PRESENTE DE FORMA EMULSIONADA, DONDE EL PROCESO ES ESPECIALMENTE ECONOMICO E INOFENSIVO DESDE EL PUNTO DE VISTA ECONOMICO. PUEDE SER ELABORADO CON EL PROCEDIMIENTO DE ACUERDO CON LA INVENCION POLVOS, GRANULADOS O PELETS PRODUCTOS INTERMEDIOS O TERMINALES PARA APLICACIONES FARMACEUTICAS, COSMETICAS, DE DIAGNOSTICO, ANALITICA O DIETETICAS (CUIDADO DE LA SALUD DE FORMA ESPECIALMENTE VENTAJOSA. TALES MEDICAMENTOS MUESTRAN POR EJEMPLO UNA BIODISPONIBILIDAD AUMENTADA, ASI COMO UNA BUENA CONSERVACION Y TOLERABILIDAD.
ES95113398T 1992-01-17 1993-01-18 Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion. Expired - Lifetime ES2133633T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4201173A DE4201173C2 (de) 1992-01-17 1992-01-17 Akutarzneimittel in Form von Dihydropyridinderivaten enthaltenden Pellets und ihre Herstellung
DE4201179A DE4201179A1 (de) 1992-01-17 1992-01-17 Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US07/876,864 US5405616A (en) 1992-01-17 1992-04-30 Means for containing active substances, having a shell of hydrophilic macromolecules, active substances and process for preparation thereof
US07/876,877 US5384129A (en) 1992-01-17 1992-04-30 Pellets containing dihydropyridine derivatives process for the production thereof and use as rapid action dosage in heart and circulatory diseases

Publications (1)

Publication Number Publication Date
ES2133633T3 true ES2133633T3 (es) 1999-09-16

Family

ID=27435369

Family Applications (2)

Application Number Title Priority Date Filing Date
ES93902034T Expired - Lifetime ES2092808T3 (es) 1992-01-17 1993-01-18 Cuerpos solidos con contenido en principio activo con una estructura a base de macromoleculas hidrofilas y procedimiento para su produccion.
ES95113398T Expired - Lifetime ES2133633T3 (es) 1992-01-17 1993-01-18 Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES93902034T Expired - Lifetime ES2092808T3 (es) 1992-01-17 1993-01-18 Cuerpos solidos con contenido en principio activo con una estructura a base de macromoleculas hidrofilas y procedimiento para su produccion.

Country Status (10)

Country Link
EP (2) EP0701815B1 (es)
JP (1) JPH07502736A (es)
AT (2) ATE142484T1 (es)
AU (1) AU679906B2 (es)
CA (1) CA2128244C (es)
DE (2) DE59303759C5 (es)
DK (2) DK0621777T3 (es)
ES (2) ES2092808T3 (es)
GR (2) GR3021223T3 (es)
WO (1) WO1993013757A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714575B1 (fr) * 1994-01-03 1996-02-02 Rhone Poulenc Nutrition Animal Nouveaux granulés contenant des organismes vivant pour l'alimentation animale.
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
ATE289865T1 (de) * 2001-03-22 2005-03-15 Cognis Iberia Sl Mikrokapseln (vii)
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2003236521A1 (en) 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
FR2843301B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US9023333B2 (en) * 2002-10-16 2015-05-05 Stefan Frahling Method of using shaped articles to apply a scaffold-forming agent to an external skin and/or hair surface of a human or an animal
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
RU2527893C2 (ru) 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
WO2008033024A2 (en) 2006-09-15 2008-03-20 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
PL2061427T3 (pl) * 2006-09-15 2011-12-30 Echo Pharmaceuticals Bv Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
EP2243470A1 (de) 2009-04-22 2010-10-27 Dr. Suwelack Skin & Health Care AG Gefriergetrockneter beschichteter Formkörper
ES2786506T3 (es) * 2012-08-01 2020-10-13 Zahra Tavakoli Composiciones congeladas fluidas que comprenden un agente terapéutico
ITMI20122145A1 (it) * 2012-12-14 2014-06-15 Velleja Res Srl Composizioni per uso orale contenenti idrolizzati di collagene, di elastina e vitamina c favorenti la deposizione di matrice extra-cellulare
LU102656B1 (de) 2021-03-11 2022-09-12 Prosecur Gmbh Flüssiges Nahrungsergänzungsmittel zur Immunstimulation, Verfahren zu dessen Herstellung sowie Verwendung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1248863B (es) * 1959-01-30
GB887901A (es) * 1960-04-13 1900-01-01
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
FR2634121B1 (fr) * 1988-07-13 1992-05-07 Imedex Procede de preparation de microparticules de collagene et produits obtenus
JPH02135052A (ja) * 1988-11-17 1990-05-23 Taiyo Kagaku Co Ltd 粒状食品の製造方法
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
FR2650502B1 (fr) * 1989-08-07 1994-05-27 Delagrange Laboratoires Nouvelle forme galenique orale ameliorant la biodisponibilite
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
EP0621775B1 (de) 1992-01-17 1997-08-06 ALFATEC-PHARMA GmbH Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
AU679905B2 (en) 1992-01-17 1997-07-17 Alfatec-Pharma Gmbh Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets
EP0623018B1 (de) 1992-01-17 1995-12-27 ALFATEC-PHARMA GmbH Verfahren zur herstellung von weichgelatinekapseln nach einem tropfverfahren
DE4221880A1 (de) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen

Also Published As

Publication number Publication date
ES2092808T3 (es) 1996-12-01
EP0701815B1 (de) 1999-06-30
JPH07502736A (ja) 1995-03-23
EP0701815A1 (de) 1996-03-20
DE59303759D1 (de) 1996-10-17
DK0701815T3 (da) 2000-02-07
DE59303759C5 (de) 2009-04-09
EP0621777A1 (de) 1994-11-02
CA2128244C (en) 1998-09-22
DE59309678D1 (de) 1999-08-05
GR3021223T3 (en) 1997-01-31
ATE142484T1 (de) 1996-09-15
AU3343293A (en) 1993-08-03
AU679906B2 (en) 1997-07-17
ATE181666T1 (de) 1999-07-15
EP0621777B1 (de) 1996-09-11
CA2128244A1 (en) 1993-07-22
WO1993013757A1 (de) 1993-07-22
GR3030675T3 (en) 1999-11-30
DK0621777T3 (da) 1996-10-21

Similar Documents

Publication Publication Date Title
ES2133633T3 (es) Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion.
DE68923763D1 (de) Anordnung von Datenzellen und Aufbau von Neuronennetzen, die eine solche Anordnung nutzen.
IT8800524V0 (it) Soletta in p.v.c. con sottofondo piatto e con la parte superiore formata da rilievi di forme varie (cilindrici o semisferici) vuoti
DE68927583D1 (de) Für menschliches Serum Albumin (HSA) kodierende DNA, Plasmide und Wirtzellen, die solche DNA enthalten sowie die Herstellung von HSA
ATE246246T1 (de) Herstellung von hämoglobin und analogen davon in nicht-erythrozytzellen
NL300062I2 (nl) Osteogene middelen.
NO954188D0 (no) Modifisert-protein- og -peptid - farmasöytika
DE68923571D1 (de) Dynamischer RAM-Speicher mit Redundanz und verbesserter Prüfbarkeit.
ATE247478T1 (de) Bioartifizielle vorrichtungen und hierfür verwendete zellhaltige matrix
DE3768694D1 (de) Kuenstliche haut und deren herstellung.
DE68903576D1 (de) Signalpeptide, die in hefe wirksam sind und ihre verwendung zur sekretorischen expression von heterologen proteinen.
DE69001609D1 (de) Herstellung von niedrigviskosen fotografischen kleinteilchen-dispersionen in gelatine.
DE69420251D1 (de) Löslicher Interferon-Rezeptor, seine Herstellung und Anwendung
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
DE3872228D1 (de) Elektrode fuer die entwicklung von sauerstoff und deren herstellungsverfahren.
DE59006688D1 (de) Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
DK29491A (da) O-glycosyleret igf-1
DE68908381D1 (de) Heteroatom enthaltende neopentylsaeure mit endstaendigen perfluoroalkylgruppen und ihre salze.
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ES2078908T3 (es) Un procedimiento para la formacion de un puente intramolecular de disulfuro en un polipeptido.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.
DE3881812D1 (de) Physiologisch aktive substanzen, probestin und prostatin und deren herstellung.
ATA270188A (de) Enantiomerenreine zwischenprodukte, deren herstellung und deren verwendung zur herstellung von enantiomerenreinem disparlure
IT8564429V0 (it) Mansarda attrezzata con cuccetta e accessori vari, da applicarsi sul padiglione di autocarri in genere.
IT8623153V0 (it) Struttura di castone perfezionato, realizzabile su anelli ed altri gioielli, atta a facilitare l'operazione di incastonatura di brillanti e simili ed a garantirne una perfetta stabilita', nella relativa sede.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701815

Country of ref document: ES